2026 Annual Meeting | SS13 - Section Showcase: No-no to Headaches: Neuro-ophthalmology and Neuro-otology in Headache Disorders
| 02:00 PM - 02:05 PM CDT | Introduction |
No-no to Headaches: Neuro-ophthalmology and Neuro-otology in Headache Disorders
Richard Baron, MD |
| 02:05 PM - 02:45 PM CDT | Speaker |
Case-based Learning
Richard Baron, MD, Aileen Antonio, MD, FAAN, David Sandlin, MD, PhD, Daniel R. Gold, DO, Noah Rosen, MD, FAAN, Nina Y. Riggins, MD, FAAN, Kristen K. Steenerson, MD, FAAN |
| 02:45 PM - 03:00 PM CDT | Q&A |
Ask the Experts
Richard Baron, MD, Aileen Antonio, MD, FAAN, David Sandlin, MD, PhD, Daniel R. Gold, DO, Noah Rosen, MD, FAAN, Nina Y. Riggins, MD, FAAN, Kristen K. Steenerson, MD, FAAN |
| Richard Baron, MD | Dr. Baron has nothing to disclose. |
| Aileen Antonio, MD, FAAN | Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. An immediate family member of Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giamarco, Mullins & Horton PC. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. Dr. Antonio has received research support from 好色先生. |
| David Sandlin, MD, PhD | Dr. Sandlin has nothing to disclose. |
| Daniel R. Gold, DO | Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care. |
| Noah Rosen, MD, FAAN | Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer . Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Rosen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. |
| Nina Y. Riggins, MD, FAAN | Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KLJ. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive, MJH Life Sciences. Dr. Riggins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SpringerNature. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities. |
| Kristen K. Steenerson, MD, FAAN | Dr. Steenerson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otolith. The institution of Dr. Steenerson has received research support from Wu Tsai Neurosciences Institute, Stanford University. |